Skip to main content
MGRX logo
MGRX
(NASDAQ)
Mangoceuticals, Inc.
$0.34-- (--)
Loading... - Market loading

Mangoceuticals (MGRX) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Mangoceuticals Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Mangoceuticals, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Revenue & Gross Profit
Revenue0.460.620.730.010.00
Cost of Revenue0.210.240.300.000.00
Gross Profit0.000.380.430.000.00
Operating Expenses
Research & Development0.000.000.000.000.00
Selling, General & Administrative18.287.908.552.000.02
Operating Expenses0.008.359.652.000.02
Operating Income0.00-7.97-9.22-1.99-0.02
Other Income/Expense
Interest Income0.000.000.000.000.00
Interest Expense0.000.010.00-0.010.00
Other Income/Expense0.00-0.740.01-0.010.00
Income
Income Before Tax-20.64-8.71-9.21-2.00-0.02
Income Tax Expense0.000.000.000.000.00
Net Income0.00-8.71-9.21-2.00-0.02
Net Income - Continuous Operations0.00-8.71-9.21-2.00-0.02
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-17.43-7.96-9.13-1.99-0.02
EBIT-19.15-8.69-9.21-1.99-0.07
Depreciation & Amortization0.000.720.080.000.00
Earnings Per Share
Basic EPS-2.00-4.00-9.00-3.00-
Diluted EPS--4.00-9.00-3.00-
Basic Shares Outstanding10.071.981.070.721.00
Diluted Shares Outstanding10.071.981.070.721.00

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.